Tyler Van Buren
Stock Analyst at TD Cowen
(4.98)
# 59
Out of 4,520 analysts
859
Total ratings
62.2%
Success rate
36%
Average return
Main Sectors:
Stocks Rated by Tyler Van Buren
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals | Downgraded: Hold | n/a | $83.86 | - | 14 | Jul 8, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | n/a | $134.00 | - | 19 | Jun 24, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $280 | $254.49 | +10.02% | 1 | Jun 23, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | n/a | $100.23 | - | 16 | Jun 23, 2026 | |
| ODTX Odyssey Therapeutics | Maintained: Buy | n/a | $17.61 | - | 2 | Jun 18, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $60 | $56.71 | +5.80% | 23 | Jun 2, 2026 | |
| ORKA Oruka Therapeutics | Maintained: Buy | n/a | $92.70 | - | 11 | May 13, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | n/a | $1.79 | - | 23 | May 13, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | n/a | $32.13 | - | 17 | May 13, 2026 | |
| ARVN Arvinas | Maintained: Hold | n/a | $8.01 | - | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.11 | - | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $22.32 | - | 14 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.69 | - | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.47 | - | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.12 | - | 8 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $71.85 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.76 | - | 10 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.76 | - | 14 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.89 | - | 3 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $32.60 | - | 13 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $20.86 | - | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 | $134.28 | +19.15% | 72 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $5.00 | - | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $81.38 | +16.74% | 36 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $28.49 | +22.85% | 27 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $31.68 | - | 14 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $62.92 | - | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.81 | - | 10 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.26 | - | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $34.96 | +71.62% | 17 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $36.01 | - | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 | $47.78 | -5.82% | 16 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $15.44 | +94.30% | 19 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 | $61.82 | -35.30% | 44 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $960 | $676.69 | +41.87% | 48 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $20 | $13.30 | +50.38% | 12 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.64 | - | 12 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.44 | - | 19 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.78 | n/a | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $5.74 | n/a | 7 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $41.03 | n/a | 1 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.29 | n/a | 12 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $51.76 | n/a | 2 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $117.25 | n/a | 17 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $54.39 | n/a | 16 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $68.26 | n/a | 21 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.05 | n/a | 3 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $32.03 | n/a | 2 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $21.71 | n/a | 13 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.22 | n/a | 11 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $39.61 | n/a | 21 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $37.31 | n/a | 6 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.93 | n/a | 13 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.97 | n/a | 2 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.86 | n/a | 9 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $312.02 | n/a | 21 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7081 | n/a | 4 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.44 | n/a | 8 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.85 | n/a | 7 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.44 | n/a | 7 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1701 | n/a | 4 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.15 | n/a | 3 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $23.12 | n/a | 3 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $314.41 | n/a | 4 | Oct 1, 2021 |
Crinetics Pharmaceuticals
Jul 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $83.86
Upside: -
Apogee Therapeutics
Jun 24, 2026
Downgraded: Hold
Price Target: n/a
Current: $134.00
Upside: -
AbbVie
Jun 23, 2026
Reiterated: Buy
Price Target: $280
Current: $254.49
Upside: +10.02%
Spyre Therapeutics
Jun 23, 2026
Maintained: Buy
Price Target: n/a
Current: $100.23
Upside: -
Odyssey Therapeutics
Jun 18, 2026
Maintained: Buy
Price Target: n/a
Current: $17.61
Upside: -
Travere Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $60
Current: $56.71
Upside: +5.80%
Oruka Therapeutics
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $92.70
Upside: -
Allogene Therapeutics
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $1.79
Upside: -
Tyra Biosciences
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $32.13
Upside: -
Arvinas
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $8.01
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $5.11
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $22.32
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $3.69
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $11.47
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $28.12
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $71.85
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $9.76
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $27.76
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $24.89
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $32.60
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $20.86
Upside: -
May 7, 2026
Maintained: Buy
Price Target: $160
Current: $134.28
Upside: +19.15%
May 7, 2026
Maintained: Buy
Price Target: $5
Current: $5.00
Upside: -
May 7, 2026
Maintained: Buy
Price Target: $95
Current: $81.38
Upside: +16.74%
May 7, 2026
Maintained: Buy
Price Target: $35
Current: $28.49
Upside: +22.85%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $31.68
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $62.92
Upside: -
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $13.81
Upside: -
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $8.26
Upside: -
May 6, 2026
Maintained: Buy
Price Target: $60
Current: $34.96
Upside: +71.62%
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $36.01
Upside: -
May 4, 2026
Maintained: Hold
Price Target: $45
Current: $47.78
Upside: -5.82%
May 4, 2026
Maintained: Buy
Price Target: $30
Current: $15.44
Upside: +94.30%
May 1, 2026
Maintained: Hold
Price Target: $40
Current: $61.82
Upside: -35.30%
Apr 29, 2026
Maintained: Buy
Price Target: $960
Current: $676.69
Upside: +41.87%
Nov 5, 2025
Maintained: Buy
Price Target: $25 → $20
Current: $13.30
Upside: +50.38%
Nov 5, 2025
Maintained: Hold
Price Target: n/a
Current: $10.64
Upside: -
Aug 8, 2025
Maintained: Hold
Price Target: n/a
Current: $3.44
Upside: -
Nov 8, 2023
Maintained: Hold
Price Target: n/a
Current: $2.78
Upside: n/a
Mar 11, 2022
Maintained: Buy
Price Target: $15
Current: $5.74
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $41.03
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $9.29
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $51.76
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $117.25
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $54.39
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $68.26
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $6.05
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $32.03
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $21.71
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $17.22
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $39.61
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $37.31
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $16.93
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $8.97
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $10.86
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $312.02
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $0.7081
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $2.44
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $17.85
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $12.44
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $0.1701
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $1.15
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $23.12
Upside: n/a
Oct 1, 2021
Rated: Hold
Price Target: n/a
Current: $314.41
Upside: n/a